Biogenic Synthesis and Characterisation of Novel Potassium Nanoparticles by Capparis spinosa Flower Extract and Evaluation of Their Potential Antibacterial, Anti-biofilm and Antibiotic Development.

Scientific researches on the synthesis, characterisation, and biological activity of potassium nanoparticles (K NPs) are extremely rare. In our study, we successfully synthesised a novel form of K NPs using Capparis spinosa (C. spinosa) flower extract as a reducing and capping agent. The formation of K NPs in new form (K2O NPs) was confirmed by UV-vis and XRD spectra. Furthermore, the FTIR results indicated the presence of specific active biomolecules in the C. spinosa extract which played a crucial role in reducing and stabilising K2O NPs. SEM imaging demonstrated that the K2O NPs exhibited irregular shapes with nanosizes ranging between 25 and 95 nm. Remarkably, the biosynthesised K2O NPs displayed considerable antibacterial activity against a wide range of multidrug-resistant (MDR) pathogenic bacteria. K2O NPs demonstrated considerable anti-biofilm activity against preformed biofilms produced by MDR bacteria. Combining K2O NPs with conventional antibiotics greatly improved their efficacy in compacting the MDR bacterial strains. Industrially, bulk form of potassium oxides was commonly used in the preparation of various antimicrobial compounds such as detergents, bleach, and oxidising solutions. The synthesis of potassium oxide in nanoform has shown remarkable biological efficacy, making it a promising therapeutic approach for pharmaceutical and medical applications.

Biosynthesis and antibacterial activity of manganese oxide nanoparticles prepared by green tea extract.

Amongst chemical and physical techniques, the biosynthesis method of metal nanoparticles has received the interest of many researchers owing to its environmental safety, simplicity and inexpensiveness. Manganese oxide nanoparticles (MnO NPs) were successfully synthesised using green tea extract as the reducing agent and characterised by UV-Vis spectroscopy, X-ray diffractometry and Fourier transform infrared spectroscopy. The shape and size of the MnO NPs were obtained by scanning electron microscopy. The size of the MnO NPs was 20-30 nm. The MnO NPs exhibited strong antibacterial activity against pathogenic bacteria, namely, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa, with inhibition zones of 12, 14 and 18 mm, respectively. Moreover, the minimum inhibitory concentration (MIC) of the MnO NPs was 12.5 U/mL as determined by resazurin microtitre assay. The activities of some antibiotics remarkably increased when combined with MnO NPs (at MIC).